These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27837170)

  • 61. Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala.
    László K; Kovács A; Zagoracz O; Ollmann T; Péczely L; Kertes E; Lacy DG; Lénárd L
    Behav Brain Res; 2016 Jan; 296():279-285. PubMed ID: 26386304
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.
    Iijima M; Yoshimizu T; Shimazaki T; Tokugawa K; Fukumoto K; Kurosu S; Kuwada T; Sekiguchi Y; Chaki S
    Br J Pharmacol; 2014 Jul; 171(14):3511-25. PubMed ID: 24654684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Binding of the non-peptide vasopressin V1a receptor antagonist SR-49059 in the rat brain: an in vitro and in vivo autoradiographic study.
    Tribollet E; Raufaste D; Maffrand J; Serradeil-Le Gal C
    Neuroendocrinology; 1999 Feb; 69(2):113-20. PubMed ID: 9986924
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of central vasopressin administration to infant rats.
    Winslow JT; Insel TR
    Eur J Pharmacol; 1993 Mar; 233(1):101-7. PubMed ID: 8472738
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Central vasopressin V1A receptor blockade alters patterns of cellular activation and prevents glucocorticoid habituation to repeated restraint stress exposure.
    Gray M; Innala L; Viau V
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2005-15. PubMed ID: 24913767
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oxytocin in the medial prefrontal cortex attenuates anxiety: Anatomical and receptor specificity and mechanism of action.
    Sabihi S; Dong SM; Maurer SD; Post C; Leuner B
    Neuropharmacology; 2017 Oct; 125():1-12. PubMed ID: 28655609
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroanatomical distribution of oxytocin and vasopressin 1a receptors in the socially monogamous coppery titi monkey (Callicebus cupreus).
    Freeman SM; Walum H; Inoue K; Smith AL; Goodman MM; Bales KL; Young LJ
    Neuroscience; 2014 Jul; 273():12-23. PubMed ID: 24814726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New opportunities in vasopressin and oxytocin research: a perspective from the amygdala.
    Stoop R; Hegoburu C; van den Burg E
    Annu Rev Neurosci; 2015 Jul; 38():369-88. PubMed ID: 26154981
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
    Kleindienst A; Dunbar JG; Glisson R; Marmarou A
    Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.
    Arai K; Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Feb; 749():98-106. PubMed ID: 25592317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence for an involvement of vasopressin in mechanism of primary dysmenorrhea and effect of the non-peptide vasopressin V1a receptor antagonist, SR 49059, on the uterus of non-pregnant women.
    Akerlund M; Bossmar T; Brouard R; Steinwall M
    Adv Exp Med Biol; 1998; 449():467-72. PubMed ID: 10026840
    [No Abstract]   [Full Text] [Related]  

  • 73. Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior.
    Han JS; Bird GC; Li W; Jones J; Neugebauer V
    J Neurosci Methods; 2005 Feb; 141(2):261-9. PubMed ID: 15661308
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently.
    Tsuchiya H; Fujinoki M; Azuma M; Koshimizu TA
    Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36650057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Involvement of oxytocin and its receptor in nociceptive modulation in the central nucleus of amygdala of rats.
    Han Y; Yu LC
    Neurosci Lett; 2009 Apr; 454(1):101-4. PubMed ID: 19429063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.
    Tsukada J; Tahara A; Tomura Y; Wada Ki ; Kusayama T; Ishii N; Yatsu T; Uchida W; Taniguchi N; Tanaka A
    Br J Pharmacol; 2001 Jul; 133(5):746-54. PubMed ID: 11429400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H
    Ghorbanzadeh V; Jafarpour A; Pirnia A; Pajouhi N; Khaksarian M; Veiskarami S; Nazari A
    Arch Physiol Biochem; 2022 Jun; 128(3):830-835. PubMed ID: 32141340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Viral vector-mediated gene transfer of the vole V1a vasopressin receptor in the rat septum: improved social discrimination and active social behaviour.
    Landgraf R; Frank E; Aldag JM; Neumann ID; Sharer CA; Ren X; Terwilliger EF; Niwa M; Wigger A; Young LJ
    Eur J Neurosci; 2003 Jul; 18(2):403-11. PubMed ID: 12887422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carbonyl) benzanilide derivatives.
    Matsuhisa A; Koshio H; Sakamoto K; Taniguchi N; Yatsu T; Tanaka A
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1566-79. PubMed ID: 9810694
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The bilevel chamber revealed differential involvement of vasopressin and oxytocin receptors in female mouse sexual behavior.
    Hayashi H; Shimizu K; Nakamura K; Nishimori K; Kondo Y
    PLoS One; 2024; 19(6):e0304703. PubMed ID: 38900750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.